Daniel J Mitchell - Net Worth and Insider Trading

Daniel J Mitchell Net Worth

The estimated net worth of Daniel J Mitchell is at least $1,995 dollars as of 2024-05-22. Daniel J Mitchell is the Director of ARCA biopharma Inc and owns about 611 shares of ARCA biopharma Inc (ABIO) stock worth over $1,980. Daniel J Mitchell is also the Director of GlobeImmune Inc and owns about 76,794 shares of GlobeImmune Inc (GBIM) stock worth over $15. Details can be seen in Daniel J Mitchell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel J Mitchell has not made any transactions after 2017-05-02 and currently still holds the listed stock(s).

Transaction Summary of Daniel J Mitchell

To

Daniel J Mitchell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel J Mitchell owns 3 companies in total, including ARCA biopharma Inc (ABIO) , GlobeImmune Inc (GBIM) , and Cardiovascular Systems Inc (CSII) .

Click here to see the complete history of Daniel J Mitchell’s form 4 insider trades.

Insider Ownership Summary of Daniel J Mitchell

Ticker Comapny Transaction Date Type of Owner
ABIO ARCA biopharma Inc 2017-05-02 director
GBIM GlobeImmune Inc 2016-03-17 director
CSII Cardiovascular Systems Inc 2006-06-27 director

Daniel J Mitchell Latest Holdings Summary

Daniel J Mitchell currently owns a total of 2 stocks. Among these stocks, Daniel J Mitchell owns 611 shares of ARCA biopharma Inc (ABIO) as of May 2, 2017, with a value of $1,980 and a weighting of 99.23%. Daniel J Mitchell also owns 76,794 shares of GlobeImmune Inc (GBIM) as of March 17, 2016, with a value of $15 and a weighting of 0.77%.

Latest Holdings of Daniel J Mitchell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABIO ARCA biopharma Inc 2017-05-02 611 3.24 1,980
GBIM GlobeImmune Inc 2016-03-17 76,794 0.00 15

Holding Weightings of Daniel J Mitchell


Daniel J Mitchell Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel J Mitchell has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the acquisition of 611 shares on May 2, 2017, which cost Daniel J Mitchell around $29,810.

According to the SEC Form 4 filings, Daniel J Mitchell has made a total of 0 transactions in GlobeImmune Inc (GBIM) over the past 5 years. The most-recent trade in GlobeImmune Inc is the sale of 21,600 shares on March 17, 2016, which brought Daniel J Mitchell around $35,856.

Insider Trading History of Daniel J Mitchell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel J Mitchell Trading Performance

GuruFocus tracks the stock performance after each of Daniel J Mitchell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel J Mitchell is -24%. GuruFocus also compares Daniel J Mitchell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel J Mitchell within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel J Mitchell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel J Mitchell

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6
Relative Return to S&P 500(%) -8

Daniel J Mitchell Ownership Network

Ownership Network List of Daniel J Mitchell

No Data

Ownership Network Relation of Daniel J Mitchell


Daniel J Mitchell Owned Company Details

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Daniel J Mitchell is the director of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ARCA biopharma Inc Insider Transactions

No Available Data

Daniel J Mitchell Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel J Mitchell. Currently GuruFocus does not have mailing address information for Daniel J Mitchell.

Discussions on Daniel J Mitchell

No discussions yet.